- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Cedara results boom as new CFO named
On the financial ropes less than two years ago, Cedara Software is fighting back. The company achieved a 50% boost in revenues in the three months ended March 31 to $13.5 million compared with $9 million in the third quarter of 2003. Net income for the
On the financial ropes less than two years ago, Cedara Software is fighting back. The company achieved a 50% boost in revenues in the three months ended March 31 to $13.5 million compared with $9 million in the third quarter of 2003. Net income for the quarter was $5.1 million, compared with a net loss of $1.6 million in 3Q the previous year. Contributing heavily to the company's improved financial picture were three major agreements Cedara struck with OEMs. Revenues from one of these were recognized in the recent third quarter. Substantial revenues from the other two are likely to be recognized next quarter. In reporting the financial results, Cedara announced the appointment of Brian Pedlar as chief financial officer. He previously served as Cedara's director of finance and administration.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
